Research News and Research

RSS

College students need a variety of messages to practice good hand hygiene

The path to poor hand sanitation is paved with good intentions, according to researchers from Kansas State and North Carolina State Universities.

5 Sep 2009

Bloodstream infections can be avoided with a daily scrub solution bath

Giving critically ill hospital patients a daily bath with a mild, soapy solution of the same antibacterial agent used by surgeons to "scrub in" before an operation can dramatically cut down, by as much as 73 percent, the number of patients who develop potentially deadly bloodstream infections, according to a new study by patient safety experts at The Johns Hopkins Hospital and five other institutions.

5 Sep 2009

Yoga reduces back pain and fights depression

People with chronic low-back problems who do yoga also do better at overcoming pain and depression than people treated conventionally for back pain, a West Virginia University study funded by the National Institutes of Health shows.

5 Sep 2009

Researchers discover the causes for the severity of RSV illness

Approximately one-half of all infants are infected with the respiratory syncytial virus (RSV) during the first year of life, and almost all children have been infected at least once by the time they reach their second birthday. Researchers at West Virginia University have discovered what makes RSV such a severe and persistent illness.

4 Sep 2009

Biden predicts health reform will pass after partisan battles

Vice President Joe Biden predicted Thursday that health reform would pass, but not before a contentious partisan battle, CQ Politics reports. "'As bleak as it looks ... you think about every change in health care, it passed by a couple of votes,' Biden said in response to a question following an address at the Brookings Institution.

4 Sep 2009

New protein fragments identified for anthrax vaccine development

Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.

4 Sep 2009

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Human Genome Sciences, Inc. today announced publication by the journal Arthritis Care & Research of an article describing the development and use of a novel evidence-based systemic lupus erythematosus (SLE) Responder Index selected as the primary endpoint of two pivotal Phase 3 clinical trials of BENLYSTA (belimumab) in serologically active patients with SLE.

4 Sep 2009

Dilafor Phase II clinical trial completes

Karolinska Development (publ) today announced that one of its portfolio companies, Dilafor AB, has concluded an extensive clinical study of its candidate drug, tafoxiparin, a new drug substance for the prevention of protracted labor during childbirth.

4 Sep 2009

Exposure to environmental tobacco smoke in European hospitals is low, says study

Tobacco use is prohibited in hospitals in many European countries, although levels of compliance with this regulation differ. A study carried out by researchers from the Catalan Institute of Oncology (ICO) has shown for the first time that exposure to environmental tobacco smoke in European hospitals is "low", and "without any notable differences" between them.

4 Sep 2009

Morning Edition: September 4, 2009

Today's headlines illustrate the following point: Everyone should enjoy the long weekend ahead, because next week Congress comes back to Washington and President Obama delivers his big health care speech -- in other words, the health policy world will be very busy.

4 Sep 2009

Finance is the only hurdle for replication of the human brain, says researcher

A model that replicates the functions of the human brain is feasible in 10 years according to neuroscientist Professor Henry Markram of the Brain Mind Institute in Switzerland. 'I absolutely believe it is technically and biologically possible. The only uncertainty is financial. It is an extremely expensive project and not all is yet secured.'

4 Sep 2009

MCNC applies for broadband recovery funding to improve access to health services

North Carolina Gov. Bev Perdue today announced that MCNC has applied to receive $28.1 million in broadband recovery funding through the American Recovery and Reinvestment Act (ARRA) to support fiber acquisition for the North Carolina Research and Education Network (NCREN) in North Carolina.

4 Sep 2009

Shire receives FDA approval for INTUNIV extended release tablets

Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.

4 Sep 2009

Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).

4 Sep 2009

StrataTest to be launched in the European market

Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year’s meeting is being held in Dresden, Germany, Sept. 13-16.

4 Sep 2009

R'09 Conference to be held for improving the material usage and energy efficiency

Everyone will be thinking about energy efficiency and resource management in Davos from the 14th to the 16th September. The primary aim of the R'09 Conference, now being held for the ninth time, is to improve the material usage and energy efficiency of manufactured products, services and processes, whether during the production, usage or even the recycling phases.

4 Sep 2009

Defective chemical bond in biological tissue may be the reason for diseases, say researchers

Researchers at Vanderbilt University Medical Center led by Billy Hudson, Ph.D., have discovered a new chemical bond in biological tissue, a fundamental discovery that helps explain evolutionary adaptation in the animal kingdom and may shed light on human disease.

4 Sep 2009

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today the initiation of two clinical trials with OSI-906, the Company’s potential first-in-class, oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor. The first study is a Phase III, multi-center study that will evaluate the use of OSI-906 for patients with locally advanced or metastatic adrenocortical carcinoma (ACC).

4 Sep 2009

State round-up: News from California, Colorado and Massachusetts

The Los Angeles Times: The California State Senate Wednesday approved a $196-million plan to tax insurance companies and capture federal dollars to keep about 700,000 children from being dropped from a governmental insurance program for the working poor. "The state Senate passed a measure to create a new tax on insurance companies and bring in federal money to rescue the decade-old Healthy Families program, which had been cut deeply in recent months as lawmakers scrambled to balance the state budget" (Bailey and Mcgreevy, 9/3).

4 Sep 2009

Fixing health care costs by changing patient behavior

Patient behavior plays a central role in fixing health. NPR reports: "Economists have long said health care, as a market, is a strange animal. A large part of this is because patients don't act like regular consumers."

4 Sep 2009